Profile data is unavailable for this security.
About the company
SMS Lifesciences India Limited is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph.Eur / IP, Famotidine USP / Ph.Eur / IP, Sildenafil Citrate USP / Ph.Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph.Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private limited.
- Revenue in INR (TTM)3.24bn
- Net income in INR178.73m
- Incorporated2006
- Employees574.00
- LocationSMS Lifesciences India LtdPlot No:19-III, Road No:71,Opp. Bharatiya Vidya Bhavan Public SchooHYDERABAD 500096IndiaIND
- Phone+91 4 066288888
- Websitehttp://www.smslife.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals Ltd | 1.04bn | 182.71m | 3.63bn | 122.00 | 19.84 | 3.75 | 16.60 | 3.48 | 14.86 | 14.86 | 84.62 | 78.64 | 0.9851 | 7.61 | 5.20 | 8,531,213.00 | 17.29 | 13.52 | 20.01 | 16.46 | 66.70 | 43.71 | 17.55 | 13.42 | 2.87 | 205.06 | 0.00 | -- | -0.1132 | 15.60 | 27.94 | 42.01 | 77.72 | -- |
| Brooks Laboratories Ltd | 817.15m | -175.35m | 3.65bn | 293.00 | -- | -- | -- | 4.47 | -6.84 | -6.84 | 31.86 | -- | -- | -- | -- | 2,788,911.00 | -- | -13.86 | -- | -22.90 | 29.09 | 26.19 | -21.46 | -27.47 | -- | 0.0861 | -- | -- | 25.76 | 7.63 | 6.26 | -- | -12.73 | -- |
| SMS Lifesciences India Ltd | 3.24bn | 178.73m | 4.15bn | 574.00 | 23.25 | -- | 12.91 | 1.28 | 59.10 | 59.10 | 1,070.58 | -- | -- | -- | -- | 5,642,058.00 | -- | 4.08 | -- | 6.73 | 34.82 | 29.68 | 5.33 | 4.46 | -- | 2.88 | -- | 2.61 | -3.04 | -4.13 | -20.68 | -12.62 | -3.09 | 0.00 |
| Venus Remedies Ltd. | 6.15bn | 221.01m | 4.16bn | 1.19k | 18.81 | 0.8424 | 8.87 | 0.6772 | 16.56 | 16.56 | 461.13 | 369.72 | 0.945 | 2.68 | 8.72 | 5,178,093.00 | 3.40 | 4.82 | 4.06 | 6.17 | 39.06 | 38.90 | 3.60 | 5.58 | 2.69 | 1,660.39 | 0.0765 | -- | 8.27 | 13.32 | 7.25 | -- | 6.38 | -- |
| Medico Remedies Ltd | 1.44bn | 85.50m | 4.79bn | 193.00 | 56.83 | -- | 41.78 | 3.32 | 1.02 | 1.02 | 17.15 | -- | -- | -- | -- | 7,474,037.00 | -- | 6.15 | -- | 12.40 | 25.07 | 25.26 | 5.93 | 3.99 | -- | 12.49 | -- | -- | 3.19 | 8.21 | 14.49 | 39.49 | -7.58 | -- |
| ZIM Laboratories Ltd | 3.82bn | 179.18m | 5.15bn | 556.00 | 28.78 | -- | 14.79 | 1.35 | 3.67 | 3.67 | 77.81 | -- | -- | -- | -- | 6,867,013.00 | -- | 3.88 | -- | 6.54 | 53.76 | 47.45 | 4.69 | 3.97 | -- | 3.44 | -- | 1.21 | -7.80 | 1.84 | -29.42 | 2.37 | 29.41 | -- |
| Kilitch Drugs (India) Ltd | 1.51bn | 125.85m | 5.16bn | 168.00 | 40.87 | -- | 36.74 | 3.41 | 7.85 | 7.85 | 94.36 | -- | -- | -- | -- | 9,003,994.00 | -- | 3.38 | -- | 4.76 | 36.87 | 35.33 | 7.03 | 6.17 | -- | 2.63 | -- | 0.00 | 10.58 | 13.35 | 39.75 | 30.69 | -19.45 | -- |
